1h Free Analyst Time
The oncology market in india is forecasted to grow by USD 2.35 billion during 2025-2030, accelerating at a CAGR of 20.0% during the forecast period. The report on the oncology market in india provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising cancer incidence and growing disease awareness, expansion of oncology healthcare infrastructure and specialized treatment centers, increasing adoption of advanced therapies and pharmaceutical innovation.
The study identifies the gradual shift toward precision and personalized oncology care as one of the prime reasons driving the oncology market in india growth during the next few years. Also, increasing role of biosimilars in expanding treatment options and expansion of integrated cancer care and multidisciplinary treatment models will lead to sizable demand in the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The oncology market in india is segmented as below:
By Type
- Cancer treatment
- Cancer diagnostics
By End-User
- Hospitals
- Diagnostic laboratories
- Diagnostic imaging centers
- Others
By Disease Type
- Breast cancer
- Lung cancer
- Blood cancer
- Colorectal cancer
- Others
By Region
- Asia
The report covers the following areas:
- Oncology market in india sizing
- Oncology market in india forecast
- Oncology market in india industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by End-user
10 Market Segmentation by Disease Type
11 Customer Landscape
12 Drivers, Challenges, and Opportunity
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global oncology market in india: Abbott Laboratories, Alkem Laboratories Ltd., AstraZeneca Plc, Baxter International Inc., Biocon Ltd., Bristol Myers Squibb Co., Cipla Inc., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., GE Healthcare Technologies, Glenmark Pharmaceuticals Ltd., Lupin Ltd., Medtronic Plc, Merck and Co. Inc., Natco Pharma Ltd., Novartis AG, Poly Medicure Ltd., Siemens Healthineers AG, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is gradual shift toward precision and personalized oncology care."
According to the report, one of the major drivers for this market is the rising cancer incidence and growing disease awareness.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Alkem Laboratories Ltd.
- AstraZeneca PLC
- Baxter International Inc.
- Biocon Ltd.
- Bristol Myers Squibb Co.
- Cipla Inc.
- Dr. Reddys Laboratories Ltd.
- F. Hoffmann La Roche Ltd.
- GE Healthcare Technologies
- Glenmark Pharmaceuticals Ltd.
- Lupin Ltd.
- Medtronic PLC
- Merck and Co. Inc.
- Natco Pharma Ltd.
- Novartis AG
- Poly Medicure Ltd.
- Siemens Healthineers AG
- Sun Pharmaceutical Industries Ltd.
- Zydus Lifesciences Ltd.
